Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells

  • October 21, 2026

  • 3 min

Share

  • 1

    Prime editing repaired a disease-causing seven-base-pair GATA2 deletion in patient-derived CD34-positive blood stem and progenitor cells.

  • 2

    After optimization, editing exceeded 70% and increased functional GATA2 alleles from 50% to as much as 77%, with higher GATA2 protein expression.

  • 3

    Edited cells retained colony-forming capacity and achieved up to 2.73-fold greater engraftment than untreated cells in immunodeficient mice.

  • 4

    Editing persisted in repopulating stem cells 16 weeks after transplantation, with no editing detected at the 20 highest-ranked predicted off-target sites.

  • 5

    PASSIGE insertion of a larger corrective GATA2 sequence reached 4.6% of alleles, and the researchers said further optimization is needed.

Original Source(s)

Related Content